Age-related changes in interleukin 2 responsiveness of resting and activated human mononuclear cells

E Ferrero1, A Manfredi, E Bianchi

  • 1Istituto Scientifico San Raffaele, Cattedra di Patologia Medica V, Università di Milano, Italy.

Haematologica
|January 1, 1991
PubMed

Insights

Aging may delay immune cell activation rather than impair it. Elderly individuals showed reduced T cell proliferation in response to Interleukin-2 (IL2) after initial days, suggesting a timing issue in immune response.

Area of Science:

  • Immunology
  • Gerontology
  • Cellular Biology

Background:

  • The "T cell model" of aging-related immune decline is increasingly accepted.
  • The specific impact of aging on Interleukin-2 (IL2) response remains uninvestigated.

Purpose of the Study:

  • To investigate the relationship between aging and the response to IL2.
  • To determine if elderly individuals exhibit altered immune cell proliferation patterns.

Main Methods:

  • Human peripheral blood mononuclear cells (PBMC) from elderly and younger donors were cultured.
  • Cells were stimulated with varying concentrations of recombinant IL2 (rIL2) and phytohemagglutinin (PHA).
  • Proliferative capacity and IL2 receptor expression were assessed over time.

Main Results:

  • PBMC from elderly donors showed comparable proliferation to younger donors initially but decreased later in culture.
  • A delayed proliferative response to rIL2 and PHA was observed in elderly individuals.
  • No significant difference in IL2 receptor-positive cells was found between age groups.

Conclusions:

  • The findings suggest a delay in PBMC activation in older donors, not a fundamental functional impairment.
  • Aging may impact the timing of immune cell responses rather than their overall capacity.
Abstract